Choosing DMTs and Ongoing Debates in Multiple Sclerosis: Robert T. Naismith, MD


The professor of neurology at Washington University in St. Louis offered an overview of the State of the Science Summit that was held on November 3, 2022, featuring a panel of expert clinicians. [WATCH TIME: 3 minutes]

WATCH TIME: 3 minutes

NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.

In this recent event, held on November 3, 2022, a panel of experts in the care of multiple sclerosis (MS) convened to discuss the recent data updates from the European Committee for Treatment and Research in Multiple Sclerosis Congress, evidence-based best practices for choosing a disease-modifying therapy, and the ongoing debate about the role of Epstein-Barr virus in MS.

Presentation topics include the following:

  • ECTRIMS Case Presentation: Evidence-Based MS Care — Robert T. Naismith, MD
  • Pro: Epstein-Barr Virus Causes Multiple Sclerosis — Anne H. Cross, MD
  • Con: Epstein-Barr Virus Causes Multiple Sclerosis — Gregory F. Wu, MD, PhD
  • Choosing a DMT — Salim Chahin, MD, MSCE
  • Clinical Neuroimaging in MS: More Than Counting Lesions — Matthew R. Brier, MD, PhD

Click the button below to watch the recent State of the Science Summit with Naismith et al.

Institutional Perspectives in Neurology, Chaired by Robert T. Naismith, MD

For more information about other events, check out our Institutional Perspectives in Neurology: Multiple Sclerosis page.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.